The N-Acetyltransferase 2 Polymorphism and Susceptibility to Inflammatory Bowel Disease: A Case-Control Study

Area of Science:

• Pharmacogenomics
• Gastroenterology
• Human Genetics

Background:

• N-acetyltransferase 2 (NAT2) is crucial for metabolizing environmental toxins and drugs.
• Genetic variations in NAT2 are known to affect individual responses to xenobiotics.
• Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, has complex genetic and environmental etiologies.

Purpose of the Study:

• To investigate the association between NAT2 gene polymorphisms and susceptibility to IBD in the Polish population.
• To identify specific NAT2 alleles and genotypes linked to increased or decreased risk of developing IBD.

Main Methods:

• Genotyping of NAT2 gene mutations (481T, 803G, 590A, 857A) using PCR-RFLP.
• Analysis of peripheral blood DNA from 101 IBD patients and 100 healthy controls from Poland.
• Statistical analysis to determine odds ratios (OR) and confidence intervals (CI) for genotype-phenotype associations.

Main Results:

• Carriage of the NAT2*5 allele was associated with a higher risk of Crohn's disease (OR=1.73).
• The NAT2*4/5 genotype showed increased prevalence in Crohn's disease patients (OR=2.77).
• The NAT2*4/6 genotype was significantly less common in IBD patients compared to controls (10.9% vs. 30.0%, p<0.01).

Conclusions:

• NAT2 gene polymorphism may play a role in modulating susceptibility to IBD in the Polish population.
• Specific NAT2 variants, such as NAT2*5 and the NAT2*4/5 genotype, are potential risk factors for Crohn's disease.
• Further research is warranted to elucidate the precise mechanisms linking NAT2 variations to IBD pathogenesis.